Published in Cancer Weekly, January 14th, 2003
In a report to the company, NCI researchers further said that 4 of 11 patients enrolled in its dose-finding study had undergone all four planned treatments. Results in three of the patients included a complete response, a partial response, and disease stabilization.
At press time, the fourth patient was awaiting response assessment.
With regard to the other seven patients:
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.